Anti-KMT6 / EZH2 antibody [EPR1409(2)]

• Supplier: Abcam
• Catalog: ab110646
• Prices: $381.00
• Sizes: 100 µl
• Host: Rabbit
• Clonality: Monoclonal
• Isotype: IgG
• Clone: EPR1409(2)
• Applications: WB
• Species Reactivities: Human
• Antigen: A synthetic peptide corresponding to residues in Human KMT6/ EZH2
• Description: Rabbit Monoclonal
• Gene: EZH2
• Conjugate: Unconjugated

Product images

All lanes : Anti-KMT6 / EZH2 antibody [EPR1409(2)] (ab110646) at 1/1000 dilutionLane 1 : Hela cell lysates Lane 2 : MCF7 cell lysates Lane 3 : K562 cell lysates Lysates/proteins at 10 µg per lane.SecondaryHRP labelled goat anti-rabbit at 1/2000 dilution

Equilibrium disassociation constant (KD)Learn more about KD Click here to learn more about KD

Product References

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. - Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.

Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stutz AM, Wang X, Gallo M, Garzia L, Zayne K, Zhang X, Ramaswamy V, Jager N, Jones DT, Sill M, Pugh TJ, Ryzhova M, Wani KM, Shih DJ, Head R, Remke M, Bailey SD, Zichner T, Faria CC, Barszczyk M, Stark S, Seker-Cin H, Hutter S, Johann P, Bender S, Hovestadt V, Tzaridis T, Dubuc AM, Northcott PA, Peacock J, Bertrand KC, Agnihotri S, Cavalli FM, Clarke I, Nethery-Brokx K, Creasy CL, Verma SK, Koster J, Wu X, Yao Y, Milde T, Sin-Chan P, Zuccaro J, Lau L, Pereira S, Castelo-Branco P, Hirst M, Marra MA, Roberts SS, Fults D, Massimi L, Cho YJ, Van Meter T, Grajkowska W, Lach B, Kulozik AE, von Deimling A, Witt O, Scherer SW, Fan X, Muraszko KM, Kool M, Pomeroy SL, Gupta N, Phillips J, Huang A, Tabori U, Hawkins C, Malkin D, Kongkham PN, Weiss WA, Jabado N, Rutka JT, Bouffet E, Korbel JO, Lupien M, Aldape KD, Bader GD, Eils R, Lichter P, Dirks PB, Pfister SM, Korshunov A, Taylor MD. Nature. 2014 Feb 27;506(7489):445-50.

Myc enforces overexpression of EZH2 in early prostatic neoplasia via - Myc enforces overexpression of EZH2 in early prostatic neoplasia via

Koh CM, Iwata T, Zheng Q, Bethel C, Yegnasubramanian S, De Marzo AM. Oncotarget. 2011 Sep;2(9):669-83.